Literature DB >> 33353065

HCV-Associated Exosomes Upregulate RUNXOR and RUNX1 Expressions to Promote MDSC Expansion and Suppressive Functions through STAT3-miR124 Axis.

Bal Krishna Chand Thakuri1,2, Jinyu Zhang1,2, Juan Zhao1,2, Lam N Nguyen1,2, Lam N T Nguyen1,2, Madison Schank1,2, Sushant Khanal1,2, Xindi Dang1,2, Dechao Cao1,2, Zeyuan Lu1,2, Xiao Y Wu1,2, Yong Jiang1, Mohamed El Gazzar1, Shunbin Ning1,2, Ling Wang1,2, Jonathan P Moorman1,2,3, Zhi Q Yao1,2,3.   

Abstract

RUNX1 overlapping RNA (RUNXOR) is a long non-coding RNA and plays a pivotal role in the differentiation of myeloid cells via targeting runt-related transcription factor 1 (RUNX1). We and others have previously reported that myeloid-derived suppressor cells (MDSCs) expand and inhibit host immune responses during chronic viral infections; however, the mechanisms responsible for MDSC differentiation and suppressive functions, in particular the role of RUNXOR-RUNX1, remain unclear. Here, we demonstrated that RUNXOR and RUNX1 expressions are significantly upregulated and associated with elevated levels of immunosuppressive molecules, such as arginase 1 (Arg1), inducible nitric oxide synthase (iNOS), signal transducer and activator of transcription 3 (STAT3), and reactive oxygen species (ROS) in MDSCs during chronic hepatitis C virus (HCV) infection. Mechanistically, we discovered that HCV-associated exosomes (HCV-Exo) can induce the expressions of RUNXOR and RUNX1, which in turn regulates miR-124 expression via STAT3 signaling, thereby promoting MDSC differentiation and suppressive functions. Importantly, overexpression of RUNXOR in healthy CD33+ myeloid cells promoted differentiation and suppressive functions of MDSCs. Conversely, silencing RUNXOR or RUNX1 expression in HCV-derived CD33+ myeloid cells significantly inhibited their differentiation and expressions of suppressive molecules and improved the function of co-cultured autologous CD4 T cells. Taken together, these results indicate that the RUNXOR-RUNX1-STAT3-miR124 axis enhances the differentiation and suppressive functions of MDSCs and could be a potential target for immunomodulation in conjunction with antiviral therapy during chronic HCV infection.

Entities:  

Keywords:  HCV; MDSCs; RUNX1; RUNXOR; immune suppression; miR124

Mesh:

Substances:

Year:  2020        PMID: 33353065      PMCID: PMC7766103          DOI: 10.3390/cells9122715

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  78 in total

1.  Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.

Authors:  Robert S Tacke; Hai-Chon Lee; Celeste Goh; Jeremy Courtney; Stephen J Polyak; Hugo R Rosen; Young S Hahn
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

2.  An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.

Authors:  Hong Wang; Wei Li; Rui Guo; Jingnan Sun; Jiuwei Cui; Guanjun Wang; Andrew R Hoffman; Ji-Fan Hu
Journal:  Int J Cancer       Date:  2014-05-02       Impact factor: 7.396

Review 3.  Novel therapies for hepatitis C - one pill fits all?

Authors:  Michael P Manns; Thomas von Hahn
Journal:  Nat Rev Drug Discov       Date:  2013-06-28       Impact factor: 84.694

Review 4.  The New RNA World: Growing Evidence for Long Noncoding RNA Functionality.

Authors:  Allison Jandura; Henry M Krause
Journal:  Trends Genet       Date:  2017-09-01       Impact factor: 11.639

5.  Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression.

Authors:  Lixin Wang; Joan S Brugge; Kevin A Janes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

Review 6.  Core binding factor at the crossroads: determining the fate of the HSC.

Authors:  Kevin A Link; Fu-Sheng Chou; James C Mulloy
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

Review 7.  The 8;21 translocation in leukemogenesis.

Authors:  Luke F Peterson; Dong-Er Zhang
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

Review 8.  Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia.

Authors:  Motomi Osato
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

Review 9.  RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

Authors:  Kentson Lam; Dong-Er Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function.

Authors:  Lin Wang; Dechao Cao; Ling Wang; Juan Zhao; Lam Nhat Nguyen; Xindi Dang; Yingjie Ji; Xiao Y Wu; Zheng D Morrison; Qian Xie; Mohamed El Gazzar; Shunbin Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  Cell Discov       Date:  2018-09-11       Impact factor: 10.849

View more
  8 in total

Review 1.  High-Mobility Group Box 1 in Spinal Cord Injury and Its Potential Role in Brain Functional Remodeling After Spinal Cord Injury.

Authors:  Zhiwu Wu; Meihua Li
Journal:  Cell Mol Neurobiol       Date:  2022-06-17       Impact factor: 5.046

Review 2.  Mitochondrial regulation during male germ cell development.

Authors:  Xiaoli Wang; Lisha Yin; Yujiao Wen; Shuiqiao Yuan
Journal:  Cell Mol Life Sci       Date:  2022-01-24       Impact factor: 9.261

3.  Therapeutic effects of peptide P140 in a mouse periodontitis model.

Authors:  Kentaro Akiyama; Kyaw Thu Aung; Laura Talamini; Olivier Huck; Takuo Kuboki; Sylviane Muller
Journal:  Cell Mol Life Sci       Date:  2022-09-15       Impact factor: 9.207

Review 4.  Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma.

Authors:  Haoming Xia; Ziyue Huang; Shuqiang Liu; Xudong Zhao; Risheng He; Zhongrui Wang; Wenguang Shi; Wangming Chen; Zhizhou Li; Liang Yu; Peng Huang; Pengcheng Kang; Zhilei Su; Yi Xu; Judy Wai Ping Yam; Yunfu Cui
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

Review 5.  Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.

Authors:  Chen Li; Yu-Qing Ni; Hui Xu; Qun-Yan Xiang; Yan Zhao; Jun-Kun Zhan; Jie-Yu He; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2021-11-10

6.  Ginsenosides Regulates Innate Immunity to Affect Immune Microenvironment of AIH Through Hippo-YAP/TAZ Signaling Pathway.

Authors:  Kehui Zhang; Jiacheng Li; Zhe Shi; Yingying Zhu; Jing Yang; Xiaolin Liu; Renye Que; Liubing Lin; Yirong Chen; Yong Li
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

7.  Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis.

Authors:  M Rotondi; F Coperchini; G Ricci; M Denegri; L Croce; S T Ngnitejeu; L Villani; F Magri; F Latrofa; L Chiovato
Journal:  J Endocrinol Invest       Date:  2020-10-06       Impact factor: 4.256

Review 8.  Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad.

Authors:  Yongtong Ge; Dalei Cheng; Qingzhi Jia; Huabao Xiong; Junfeng Zhang
Journal:  Immune Netw       Date:  2021-05-26       Impact factor: 6.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.